A paradigm for Africa-centric vaccine development in Equatorial Guinea
-
Published:2024-05
Issue:5
Volume:40
Page:362-366
-
ISSN:1471-4922
-
Container-title:Trends in Parasitology
-
language:en
-
Short-container-title:Trends in Parasitology
Author:
Billingsley Peter F.ORCID,
Richie Thomas L.ORCID,
Abdulla SalimORCID,
Ondo’o Ayekaba Mitoha,
Daubenberger Claudia A.ORCID,
Garcia Guíllermo A.ORCID,
Hoffman Stephen L.ORCID
Reference14 articles.
1. Trends in parasite prevalence following 13 years of malaria interventions on Bioko Island, Equatorial Guinea: 2004–2016;Cook;Malar. J.,2018
2. Sporozoite immunization: innovative translational science to support the fight against malaria;Richie;Expert Rev. Vaccines,2023
3. The Equatoguinean malaria vaccine initiative: from the launching of a clinical research platform to malaria elimination planning in Central West Africa;Billingsley;Am. J. Trop. Med. Hyg.,2020
4. Increase of dose associated with decrease in protection against controlled human malaria infection by PfSPZ vaccine in Tanzanian adults;Jongo;Clin. Infect. Dis.,2020
5. Safety and differential antibody and T-cell responses to the Plasmodium falciparum sporozoite malaria vaccine, PfSPZ vaccine, by age in Tanzanian adults, adolescents, children, and infants;Jongo;Am. J. Trop. Med. Hyg.,2019